ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
559 hedge funds and large institutions have $26B invested in Alexion Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 72 funds opening new positions, 254 increasing their positions, 178 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more capital invested
Capital invested by funds: $26B → $26B (+$69.5M)
0% less funds holding
Funds holding: 561 → 559 (-2)
Holders
559
Holding in Top 10
19
Calls
$675M
Puts
$459M
Top Buyers
| 1 | +$430M | |
| 2 | +$394M | |
| 3 | +$245M | |
| 4 |
BlackRock
New York
|
+$158M |
| 5 |
TP
Third Point
New York
|
+$152M |
Top Sellers
| 1 | -$1.09B | |
| 2 | -$685M | |
| 3 | -$303M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$224M |
| 5 |
JPMorgan Chase & Co
New York
|
-$214M |